Oncogenic roles of long non-coding RNAs in essential glioblastoma signaling pathways

Mina Lashkarboloki1, Amin Jahanbakhshi2, Seyed Javad Mowla1

  • 1Genetics Department, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

Journal of Neurogenetics
|August 22, 2024
PubMed

Insights

Glioblastoma multiforme (GBM), a deadly brain cancer, is driven by oncogenic long non-coding RNAs (lncRNAs). Targeting these lncRNAs offers a promising new strategy for developing effective glioblastoma treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioblastoma multiforme (GBM) is an aggressive brain cancer with poor patient survival rates.
  • Current treatments have shown limited success, necessitating novel therapeutic strategies.
  • Dysregulation of oncogenes and tumor suppressor genes initiates carcinogenic pathways in GBM.

Purpose of the Study:

  • To identify and characterize oncogenic long non-coding RNAs (lncRNAs) involved in glioblastoma multiforme (GBM) pathogenesis.
  • To explore the potential of lncRNAs as diagnostic, prognostic, and therapeutic targets for GBM.
  • To classify identified oncogenic lncRNAs based on the signaling pathways they regulate.

Main Methods:

  • Literature review and analysis of existing studies on lncRNAs in glioblastoma.
  • Identification of key oncogenic lncRNAs implicated in GBM development and progression.
  • Classification of lncRNAs according to their regulated target genes and associated signaling pathways.

Main Results:

  • Multiple oncogenic lncRNAs were identified as significant contributors to GBM.
  • These lncRNAs play critical roles in regulating gene transcription, translation, and epigenetic modifications.
  • The study classified these oncogenic lncRNAs into distinct signaling pathways relevant to glioblastoma.

Conclusions:

  • Oncogenic lncRNAs are crucial players in glioblastoma multiforme (GBM) carcinogenesis.
  • lncRNAs represent promising biomarkers for GBM diagnosis and prognosis.
  • Targeting oncogenic lncRNAs presents a potential novel therapeutic avenue for treating glioblastoma.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K